98
Views
11
CrossRef citations to date
0
Altmetric
Review

Spotlight on elotuzumab in the treatment of multiple myeloma: the evidence to date

Pages 6037-6048 | Published online: 05 Oct 2016

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.